Table 4 Laboratory values at baseline and in the acute and chronic periods following TACE
Laboratory parameter | Patient number, n | Baseline (value closest to index TACE) | Acute period (highest value) | P-value acute vs baseline | Chronic period (latest value) | P-value chronic vs baseline |
|---|---|---|---|---|---|---|
Bilirubin, mg/dL | 462 | |||||
Mean (SD) | 1.5 (1.1) | 2.2 (2.9) | – | 2.3 (4.1) | – | |
Median (range) | 1.2 (0.09–6.9) | 1.4 (0.3–37.9) | P < .0001 | 1.2 (0.2–41.3) | P = .008 | |
Albumin, g/dL | 442 | |||||
Mean (SD) | 3.2 (0.7) | 2.9 (0.7) | – | 3.1 (0.7) | – | |
Median (range) | 3.3 (1.6–4.9) | 2.8 (1.0–4.8) | P < .0001 | 3.1 (1.4–4.8) | P < .0001 | |
AST, U/L | 446 | |||||
Mean (SD) | 75.9 (61.5) | 152.6 (270.4) | 88.5 (187.3) | |||
Median (range) | 62 (11–844) | 82 (13–3341) | P < .0001 | 60 (9–3739) | P = .600 | |
ALT, U/L | 441 | |||||
Mean (SD) | 59.5 (49.6) | 122.1 (266.8) | 62.1 (82.8) | |||
Median (range) | 45 (9–450) | 60 (7–3198) | P < .0001 | 42 (7–1122) | P = .08 | |
INR | 251 | |||||
Mean (SD) | 1.3 (0.4) | 1.6 (0.9) | 1.5 (0.6) | |||
Median (range) | 1.2 (0.9–3.2) | 1.3 (0.9–6.9) | P < .0001 | 1.2 (0.9–6.9) | P < .0001 |